Every year, some of the biggest names in cardiovascular technologies come together in one place for TCT.
This year’s 35th edition of the Transcatheter Cardiovascular Therapeutics annual scientific symposium was no different in San Francisco.
Usual suspects like Medtronic and Abbott released data covering a range of products, while other big names like Edwards, GE HealthCare and more had positive updates on their own technologies.
Last year’s TCT event highlighted some significant trends in the cardiovascular space. Let’s see what this year’s symposium brought.Abbott’s TriClip, MitraClip shine along with drug-eluting stent
Results from Abbott’s TRILUMINATE pivotal trial reinforced the safety and effectiveness of the TriClip system. Abbott also shared data from the MitraClip EXPAND G4 real-world registry at TCT 2023.
TriClip, a transcatheter edge-to-edge repair (TEER) system, treats patients with symptomat…